Harrold, L. ., Litman, H. ., Saunders, K. ., Dandreo, K. ., Gershenson, B. ., Greenberg, J. ., … Yassine, M. . (2018). One-year risk of serious infection in patients treated with certolizumab pegol as compared with other TNF inhibitors in a real-world setting: data from a national U.S. rheumatoid arthritis registry. Arthritis Research & Therapy, 20(1), 2. https://doi.org/10.1186/s13075-017-1496-5 (Original work published 2018)